Abstract: INFO05-SA
NEPHrotic Syndrome from Childhood to Adulthood: Creating a NETwork for Research and Care - the NEPHNET Project
Session Information
- Informational Posters - 3
November 08, 2025 | Location: Exhibit Hall, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Glomerular Diseases
- No subcategory defined
Authors
- Vivarelli, Marina, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Colucci, Manuela, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Giannini, Carolina, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Ricci, Giulia, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Conversano, Ester, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Martelli, Giorgio, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Gargiulo, Antonio, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Angeletti, Andrea, Istituto Giannina Gaslini, Genoa, Liguria, Italy
- Caridi, Gianluca, Istituto Giannina Gaslini, Genoa, Liguria, Italy
- Grandaliano, Giuseppe, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy
- Ambrogio, Martina, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Lazio, Italy
- Stallone, Giovanni, Azienda Ospedaliera Universitaria Foggia, Foggia, Apulia, Italy
- Emma, Francesco, Ospedale Pediatrico Bambino Gesu IRCCS, Rome, Lazio, Italy
- Zaza, Gianluigi, Azienda Ospedaliera Universitaria Foggia, Foggia, Apulia, Italy
Group or Team Name
- NEPHNET.
Description
NEPHNET is a multicenter, prospective, observational, non-profit cohort study, aiming at establishing an Italian collaborative network for collecting data and biological samples from pediatric and adult patients affected by glomerulopathies, creating an integrated platform for reproducible clinical and research studies (Figure 1). The network includes four hub centers: for pediatric patients, Bambino Gesù Children’s Hospital-IRCCS and IRCCS-Istituto Giannina Gaslini; for adult patients, Fondazione Policlinico Gemelli and Policlinico Riuniti di Foggia. Clinical data are currently being collected in pseudonymized form using the REDCap platform as a disease registry, and biological samples are being gathered longitudinally in an integrated biobank (Table 1).
The effectiveness of this approach in creating an integrated platform will be validated through ongoing pilot studies aimed at identifying multifactorial prognostic biological models.
Figure 1. Design of the NEPHNET Study.
Table 1. Enrolled patients and collected biological samples.
Funding
- Ministero della Salute - PNRR 2022